相关实验视频

Updated: Jan 12, 2026

An Instrumented Pull Test to Characterize Postural Responses

An Instrumented Pull Test to Characterize Postural Responses

Published on: April 6, 2019

用仪器拉动测试评估帕金森病的姿势不稳定:临床药理学影响

Giovanni Mostile¹, Federico Contrafatto², Marco Cultraro²

¹Department of Medical, Surgical Sciences and Advanced Technologies "G.F. Ingrassia", University of Catania, Catania, Italy; Oasi Research Institute - IRCCS, Troina, Italy.

Parkinsonism & related disorders

|November 2, 2025

概括

总时间 (TT) 有效量化了帕金森病 (PD) 患者的姿势不稳定性 (PI),并显示了对利沃多巴 (LD) 的反应. 这一指标有助于区分稳定的PD和不稳定的PD,有助于治疗评估.

科学领域:

神经学神经学
生物医学工程生物医学工程
运动障碍运动障碍

背景情况:

帕金森病 (PD) 中的姿势不稳定 (PI) 缺乏关于利沃多巴 (LD) 响应性的定量研究.
稳定和不稳定的PD受试者之间的准确歧视是具有挑战性的.

研究的目的:

在LD治疗的PD患者中定量评估PI.
建立一种可靠的方法来区分稳定和不稳定的PD.
评估LD对PI的急性影响.

主要方法:

招募了28名PD患者,分为PD与姿势稳定 (PD-PS) 和PD与PI组.
使用仪器拉力测试,通过光动力学系统跟踪胸骨标记.
测量总时间 (TT) 从姿势变化开始到恢复的时间在OFF和ON LD状态.

主要成果:

在健康对照组 (HC),PD患者,PD-PS和PD-PI组之间,总时间 (TT) 显著不同.
在稳定和不稳定试验之间,以及在LD给药前/后,TT值存在显著差异.
3.64s的TT值准确地 (83.2%) 区分了稳定和不稳定的试验.

结论:

总时间 (TT) 作为PD中PI的可靠生物标志物.
莱沃多巴 (LD) 给药改变了TT,这表明多巴胺基机制是PDPI的基础.

关键词:

利沃多帕 (Levodopa) 是一种可靠的药物.光电子系统光电子系统帕金森病的疾病.姿势不稳定性姿势不稳定性拉动测试拉动测试

更多相关视频

Computerized Dynamic Posturography for Postural Control Assessment in Patients with Intermittent Claudication

Computerized Dynamic Posturography for Postural Control Assessment in Patients with Intermittent Claudication

Published on: December 11, 2013

Evaluating Postural Control and Lower-extremity Muscle Activation in Individuals with Chronic Ankle Instability

Evaluating Postural Control and Lower-extremity Muscle Activation in Individuals with Chronic Ankle Instability

Published on: September 18, 2020

相关概念视频

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...